Hiligsmann, MickaëlDellaert, Benedict GDirksen, Carmen DWatson, VerityBours, SandrineGoemaere, StefanReginster, Jean-YvesRoux, ChristianMcGowan, BernieSilke, CarmelWhelan, BryanDiez-Perez, AdolfoTorres, ElisaPapadakis , GeorgiosRizzoli, ReneCooper, CyrusPearson, GillBoonen, Annelies2018-04-062018-04-062017-07Hiligsmann, M, Dellaert, B G, Dirksen, C D, Watson, V, Bours, S, Goemaere, S, Reginster, J-Y, Roux, C, McGowan, B, Silke, C, Whelan, B, Diez-Perez, A, Torres, E, Papadakis , G, Rizzoli, R, Cooper, C, Pearson, G & Boonen, A 2017, 'Patients’ preferences for anti-osteoporosis drug treatment : a cross-European discrete-choice experiment', Rheumatology, vol. 56, no. 7, pp. 1167-1176. https://doi.org/10.1093/rheumatology/kex0711462-0324http://hdl.handle.net/2164/10298Acknowledgements We would like to thank all participating centres: the Unit for Osteoporosis and Metabolic Bone from Ghent University Hospital (Belgium); the University Center for Investigation in Bone and Articular Cartilage Metabolism in Liege (Belgium); the Fracture Clinic of the Maastricht University Medical Center (Netherlands); the Bone Unit of Paris Descartes University, Paris (France); The North Western Rheumatology Unit, Our Lady’s Hospital, Manorhamilton and the Sligo University Hospital (Ireland); the Musculoskeletal Research Unit and RETICEF from the Universitat Auto` noma de Barcelona (Spain); the Division of Bone Diseases from the Geneva University Hospitals (Switzerland); the MRC Lifecourse Epidemiology Unit from the University of Southampton (UK) for helping us in data collection; Ed Porquie, our patient partner; Wafa Ben Sedrine, Ivette Essers and Wilco Tilburgs for data entry; and all the patients for their participation. Funding This work was supported by Amgen. The funding agreement between Maastricht University and Amgen ensured the authors’ independence in designing the study (including selection of attributes and levels), interpreting the data, and writing and publishing the report. Other participating centres were compensated by Maastricht University for their participation in the study.107499523317534907engCross-Country Comparisondiscrete choice experimentdrug treatmentosteoperosispatientspreferencesR MedicineRJournal article10.1093/rheumatology/kex071567